Ethambutol exerts its antibacterial effect by inhibiting the synthesis of RNA in tuberculosis bacteria. It has no cross-resistance with other anti-tuberculosis drugs, and the development of resistance is relatively slow. Isoniazid does not easily pass through the blood-brain barrier, with a permeability ratio of 10% to 50%. The dosage for both adults and children is 15-25 milligrams per kilogram of body weight per day. Initially, it can be administered at 25 milligrams per kilogram of body weight per day, and after two months, it can be reduced to 15 milligrams per kilogram of body weight per day. It can be taken simultaneously with isoniazid and rifampin in a single dose. Common adverse reactions include retrobulbar optic neuritis, allergic reactions, drug-induced rashes, and skin and mucosal damage. Retrobulbar optic neuritis can be treated with high doses of vitamin B1 and vasodilators, and if necessary, nicotinamide can be injected retrobulbarly. Most cases can recover within six months.

